Cargando…
Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures
In the mid‐90s, hepatitis B virus (HBV)‐directed immune responses were for the first time investigated in detail and revealed suboptimal T‐cell responses in chronic HBV patients. Based on these studies, therapeutic vaccination exploiting the antigen presentation capacity of dendritic cells to prime...
Autores principales: | Jansen, Diahann TSL, Dou, Yingying, de Wilde, Janet W, Woltman, Andrea M, Buschow, Sonja I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809700/ https://www.ncbi.nlm.nih.gov/pubmed/33489122 http://dx.doi.org/10.1002/cti2.1232 |
Ejemplares similares
-
CD4(+) T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy
por: Buschow, Sonja I., et al.
Publicado: (2021) -
Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding Strength
por: de Beijer, Monique T. A., et al.
Publicado: (2020) -
The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design
por: Kessler, Amy L., et al.
Publicado: (2020) -
The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function
por: van der Aa, Evelyn, et al.
Publicado: (2016) -
Next generation vaccines
Publicado: (2014)